Company expects to receive a negative opinion following oral explanation feedback and intends to request re-examination upon review of formal adoption. Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) ...
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Company was informed by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results